← Back
$TARA All transactions

Protara Therapeutics, Inc.

▲ BUY
7 / 10

Conviction

$ Value

$64K

Shares

20,000

Price

$3

Filed

May 19

Why this score? (7/10)
  • Open market buy (+3)
  • % of holdings >= 20% (+2)
  • Director (+1)
  • Not a 10b5-1 plan (+1)

Insider

Name

Levy Richard S

Title

CIK

0001454983

Roles

Director

Transaction Details

Transaction Date

2025-05-14

Code

P

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

51,000

Footnotes

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.15 to $3.22, inclusive. The reporting person undertakes to provide to TARA, any security holder of TARA, or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

Filing Info

Accession No.

0001213900-25-045399

Form Type

4/A

Issuer CIK

0001359931

Levy Richard S's History

Date Ticker Type Value
2025-07-01 KNSA M
2025-07-01 KNSA A $0
2025-07-01 KNSA M $0
2025-06-30 KOD A $0
2025-06-20 MDGL A $0
2025-06-20 MDGL A $0
2025-06-12 TARA A $0
2025-06-05 KNSA M
2025-06-05 KNSA M $0
2025-06-03 KNSA A $0

Other Insiders at TARA (90d)

Insider Bought Sold Last
Zummo Jacqueline
Chief R&D Officer
$125K 2026-04-08